Individuals with Down syndrome have a 90% lifetime risk of developing Alzheimer’s disease.
Sigan Hartley
METabolic Health, Lifestyle, and Risk of Co-Occurring Health Conditions in Down Syndrome (MET-DS) – (Hartley)
The METabolic Health, Lifestyle, and Risk of Co-Occurring Health Conditions in Down Syndrome (MET-DS) study is part of the NIH INCLUDE Project (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndrome) and its …
A family’s commitment to Down syndrome research at the Waisman Center spans four decades and counting
When Heather Huismann was in middle school she called the police on her teacher. “He was not teaching me very well,” Heather says.
Advising research through the lens of lived experience: How individuals with disabilities and their families are shaping research
NOTE: Each individual interviewed for this story stated their preference between person-first or identity-first language. The language used reflects the preference of each person. Researchers interviewed use identity-first language in alignment with the preferences of …
Sigan Hartley, research team receive $9 million National Institutes of Health grant to study Down syndrome
Sigan Hartley, 100 Women Distinguished Chair in Human Ecology and Human Development & Family Studies professor, and a team of researchers have received a $9 million grant from the National Institutes of Health (NIH).
Sigan Hartley, PhD – Slide of the Week
AT(N) biomarker profiles and Alzheimer’s disease in People with Down syndrome
Neurodegeneration research at the Waisman Center from gene to organelle to cell to brain
Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), Charcot-Marie-Tooth disease, and retinitis pigmentosa all have different manifestations and affect different body functions, but they are all connected by one mechanism: neurodegeneration.
Understanding the connection between Down syndrome and Alzheimer’s disease
Allison and Amber Westemeier get excited every time they take a trip to the Waisman Center from Oshkosh, WI.
The beginnings and evolution of brain imaging at the Waisman Center
The development of brain imaging techniques has helped us understand emotion, intellectual and developmental disabilities, and neurodegenerative diseases in ways we could not before.
Weight loss may be early predictor of Alzheimer’s disease in Down syndrome
Unintentional weight loss in people with Down syndrome may predict the onset of Alzheimer’s disease long before typical cognitive symptoms like memory loss and dementia are apparent.